Intrinsic Value of S&P & Nasdaq Contact Us

ViewRay, Inc. VRAY NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.25
+24900%

ViewRay, Inc. (VRAY) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 3 Buy, 8 Hold.

The consensus price target is $6.25 (low: $4.00, high: $8.00), representing an upside of 24900% from the current price $0.03.

VRAY Stock — 12-Month Price Forecast

$6.25
▲ +24,900.00% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for ViewRay, Inc., the average price target is $6.25, with a high forecast of $8.00, and a low forecast of $4.00.
The average price target represents a +24,900.00% change from the last price of $0.03.
Highest Price Target
$8.00
Average Price Target
$6.25
Lowest Price Target
$4.00

VRAY Analyst Ratings

Hold
11
Ratings
3 Buy
8 Hold
Based on 11 analysts giving stock ratings to ViewRay, Inc. in the past 3 months
Rating breakdown
Buy
3 27%
Hold
8 73%
27%
Buy
3 analysts
73%
Hold
8 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message